The Latest Cardiac and Vascular News
Contract Offers Increased Savings to More than Half of Nation’s Healthcare Organizations for BIOTRONIK’s Coronary Products Including the Orsiro Drug Eluting Stent LAKE OSWEGO, Ore., June 1, 2020 /PRNewswire/ — BIOTRONIK today announced that it has received a group purchasing contract from Vizient, Inc., the largest, member-driven, healthcare performance improvement company in the United States. The contract increases access to […]
BIOTRONIK’s Ultrathin-Strut Drug-Eluting Stent Soon Available in China Following Market Approval BEIJING, China and BUELACH, Switzerland, October 30, 2019 – BIOTRONIK announced today that its Orsiro® coronary drug-eluting stent (DES) has been approved for sale in China by the National Medical Products Administration. The company expects to make the device available to Chinese patients and physicians in the coming […]
